Observational Prolonged Trial in Myotonic Dystrophy Type 1

NACompletedINTERVENTIONAL
Enrollment

255

Participants

Timeline

Start Date

April 2, 2014

Primary Completion Date

March 29, 2016

Study Completion Date

October 17, 2016

Conditions
Myotonic Dystrophy Type 1
Interventions
BEHAVIORAL

Behavioural change intervention

The intervention is cognitive behaviour therapy (CBT). The CBT consists of six different modules. All patients will start with individual goal setting and psycho-education about the role of cognitive-behavioural variables in the disabilities patients' experience. The patient formulates his or her treatment goals in concrete terms and later on in the therapy the goals are realised step by step by the patient. The treatment is tailored to the patient's problems: which of the six modules a patient will receive is dependent on the scores on measures that have been collected at baseline assessment. Based on our previous experience with modular interventions we expect that most patients will receive less than four modules.

Trial Locations (4)

Unknown

Assistance Publique-Hospitaux de Paris, Paris

Friedrich Naur Institute, Munich

Radboud University Nijmegen Medical Centre, Nijmegen

NE1 3BZ

Newcastle University, Newcastle

All Listed Sponsors
collaborator

University of Newcastle Upon-Tyne

OTHER

collaborator

Ludwig-Maximilians - University of Munich

OTHER

collaborator

Assistance Publique - Hôpitaux de Paris

OTHER

lead

Radboud University Medical Center

OTHER

NCT02118779 - Observational Prolonged Trial in Myotonic Dystrophy Type 1 | Biotech Hunter | Biotech Hunter